About Clozex Medical
Clozex Medical is a private company based in W. Bridgewater, Massachusetts. It has reported $10,434,191 raised in three offerings on Form D since October 2018.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 1, 2023 | Mar 8, 2024 | $2,999,529of $3.0M target | 27 | $111K | DebtRule 506(b) | Form D ↗ |
| Oct 16, 2020 | Feb 12, 2021 | $2,951,647of $4.0M target | 35 | $84,333 | DebtRule 506(b) | Form D ↗ |
| Oct 16, 2018 | Oct 30, 2018amended Jun 12, 2019 | $4,483,015of $6.2M target | 46 | $97,457 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, three offerings | $10,434,191 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Clozex Medical's Form D filed Mar 8, 2024.
TA
Tony Antonaccio
Director
GZ
Gary Zentner
Director
DL
Dr. Lazor
Director
NP
Nick Patterson
Director
JL
Joseph Lamb
Director
MM
Mark Madden
Secretary and director
DR
Dr. Rubash
Director
Earlier filings also listed Michael Lebner (director, last listed Feb 2021), Joseph Cucolo (director, last listed Feb 2021), Harry Rubash (director, last listed Feb 2021), Francis Fedorowicz (ceo, last listed Feb 2021) and John Schandler (director, last listed Jun 2019).